Treatment
Treatment literacy materials that cover the basics of hepatitis C treatment, research on efficacy in different key populations, and global treatment uptake.
Materials in this section
Measurements for HCV Cure Could Be Done Earlier Among People Who Inject Drugs
Measurements taken for HCV cure at 4 weeks produced identical results for people who inject drugs as those taken at 12 weeks; Measurements taken at treatment completion also had high concordance. More
Hepatitis C Cure Can Be Assessed 4 Weeks After Treatment
Measuring HCV viral load at 4 weeks posttreatment predicts a cure as well as sustained virological response at 12 weeks. More
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
A 4-week course of glecaprevir/pibrentasvir achieved sustained virologic response in 84% of patients with early HCV infection in the PURGE-C trial, suggesting potential for shorter, more accessible treatment regimens pending further validation. More
Recently Pregnant Women With Hepatitis C Face Gaps in Treatment
Among people starting treatment for opioid use, recently pregnant women were the least likely to receive antiviral therapy for HCV. More
Short Course Therapy With Glecaprevir/Pibrentasvir for Early Hepatitis C Virus Infection: PURGE-C
Simplified approaches to treatment are critical for HCV elimination and are particularly relevant for populations difficult to retain in care. More
More Effective and Affordable Treatment Strategies for Hepatitis C
Innovative study identifies more effective and affordable treatment strategies for hepatitis C. More
Telemedicine Addiction Treatment Is an Effective Way to Offer Treatment for Hepatitis C
A report supports telehealth for opioid use disorder as an avenue to reach people at high risk of hepatitis C and treat those infected. More
Health Economic Outcomes of a Minimal Monitoring Approach to Providing HCV Therapy
The ACTG A5360 trial demonstrated that HCV treatment without planned on-treatment monitoring is safe and effective. More
Integrated Hepatitis C Care in Syringe Service Programs Improves Outcomes for People Who Inject Drugs
Tailored models within syringe service programs can overcome barriers and improve HCV cure rates in underserved populations. More
HCV and HIV Coinfection: Decreasing Barriers to an HCV Cure With Use of a Simplified Treatment Algorithm
In 2023, the AASLD/IDSA treatment guidelines were updated to include the addition of the simplified algorithm in treatment-naive individuals with HIV/HCV coinfection. More
